[1] Archibald EG. Inborn Errors of Metabolism[M]. London:Oxford Univercity Press,2013:17.
[2] Roden DM, Wilke RA, Kroemer HK, et al. Pharmacogenomics:the genetics of variable drug responses[J]. Circulation, 2011,123(15):1661-1670.
[3] Feero WG, Guttmacher AE, Collins FS. Genomic medicine-an updated primer[J]. N Engl J Med,2010,362(21):2001-2011.
[4] Beier MT, Panchapagesan M, Carman LE. Pharmacogenetics:has the time come for pharmacists to embrace and implement the science[J]. Consult Pharm,2013,28(11):696-711.
[5] U.S. National Library of medicine. Genetics home reference:the library[EB/OL].[2014-02-25]. http://ghr.nlm.nih.gov/glossary=personalizedmedicine.
[6] Swen JJ, Nijenhuis M, de Boer A, et al. Pharmacogenetics:from bench to byte-an update of guidelines[J].Clin Pharmacol Ther,2011,89(5):662-673.
[7] O'Connor SK, Ferreri SP, Michaels NM,et al.Exploratory planning and implementation of a pilot pharmacogenetic program in a community pharmacy[J]. Pharmacogenomics, 2012,13(8):955-962.
[8] ASHP statement on the pharmacist's role in clinical pharmacogenomics[J]. Am J Health Syst Pharm, 2015,72(7):579-581.
[9] Genetics/genomics competency map for pharmacists[EB/OL].[2015-08-20].http://g-2-c-2.org/competency/pharmacist.
[10] Ferro WG, Kuo GM, Jenkins JF, et al. Pharmacist education in the era of genomic medicine[J]. J Am Pharm Assoc(2003),2012,52(5):e113-e121.
[11] Hicks JK, Crews KR, Hoffman JM, et al. A cliniciandriven automated system for integration of pharmacogenetic interpretations into an electronic medical record[J]. Clin Pharmacol Ther,2012,92(5):563-566.
[12] Budnitz DS, Lovegrove MC, Shehab N, et al. Emergency hospitalizations for adverse drug events in older Americans[J]. N Engl J Med,2011,365(21):2002-2012.
[13] American society of health-system pharmacists. ASHP policy positions 1982-2013[EB/OL].http://www.ashp.org/DocLibrary/BestPractices/policypositionsonly2013.aspx.
[14] Crews KR, Cross SJ, McCormick JN, et al. Development and implementation of a pharmacist-managed clinical pharmacogenetics service[J]. Am J Health Syst Pharm, 2011,68(2):143-150.
[15] Charland SL, Agatep BC, Herrera V, et al. Providing patients with pharmacogenetic test results affects adherence to statin therapy:results of the additional KIF6 risk offers better adherence to statins (AKROBATS) trial[J]. Pharmacogenomics J, 2014,14(3):272-280.
[16] Kisor DF, Bright DR, Conaway M, et al. Pharmacogenetics in the community pharmacy:thienopyridine selection post-coronary artery stent placement[J]. J Pharm Pract, 2014,27(4):416-419.
[17] Pharmacists' role in pharmacogenomics increasing in an age of precision medicine[EB/OL].[2016-08-03].http://www.pharmacytoday.org/article/S1042-0991(16)30528-X/fulltext.
[18] Shin J, Kayser SR, Langaee TY. Pharmacogenetics:from discovery to patient care[J]. Am J Health Syst Pharm, 2009,66(7):625-637.
[19] Relling MV, Klein TE. CPIC:clinical pharmacogenetics implementation consortium of the pharmacogenomics research network[J]. Clin Pharmacol Ther,2011,89(3):464-467.
[20] Pharmacogenomics knowledge base. Drug labels[EB/OL].http://www.pharmgkb.org/view/drug-labels.do
[21] Table of pharmacogenomic biomarkers in druglabeling[EB/OL].http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm
[22] 徐婵娟,徐玉萍,王春松,等.临床药师参与1例华法林个体化抗凝中基因型检测的临床实践[J].中国医院用药评价与分析,2015,15(9):1256-1258.
[23] 刘洪涛,连玉菲,庞国勋,等.临床药师参与1例老年心血管病患者的个体化抗血小板治疗实践[J].药学与临床研究,2016,24(2):170-171.
[24] 魏安华,顾智淳,李娟,等.3例氯吡格雷抵抗患者的药学监护[J].医药导报,2015, 34(12):1668-1670.